Clinical Trial Update: D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

This document summarizes a Phase 1/2 clinical trial evaluating D-CIK cells combined with chemotherapy for non-small cell lung cancer, with the current trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• D-CIK (D-CIK cells)

Snippet

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD | Conditions: Lung Cancer, Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN